Dosing & Administration

IWILFIN is an oral tablet taken twice daily for 2 years

(or until recurrence of disease or unacceptable toxicity)1

Recommended dosage: 1 to 4 tablets based on Body Surface Area (BSA)

ft
in
lb
m2
Recommended dosage based on BSA
BSA (m2)Dosage
Error: Values entered don’t match approved dosing parameters. Please try again.
>1.5768 mg (4 tablets) orally twice a day
0.75 to 1.5576 mg (3 tablets) orally twice a day
0.5 to <0.75384 mg (2 tablets) orally twice a day
0.25 to <0.5192 mg (1 tablet) orally twice a day

BSA should be evaluated every 3 months from initiation of dosing and throughout the duration of treatment to determine if a dose adjustment is needed.

m2
Recommended dosage based on BSA
BSA (m2)Dosage
Error: Values entered don’t match approved dosing parameters. Please try again.
>1.5768 mg (4 tablets) orally twice a day
0.75 to 1.5576 mg (3 tablets) orally twice a day
0.5 to <0.75384 mg (2 tablets) orally twice a day
0.25 to <0.5192 mg (1 tablet) orally twice a day

BSA should be evaluated every 3 months from initiation of dosing and throughout the duration of treatment to determine if a dose adjustment is needed.

This Dosing Calculator is intended for use only by qualified healthcare providers. All calculations should be confirmed before use.

US WorldMeds makes no claims as to the accuracy of the information contained herein.

IWILFIN is available as 192-mg round, white to off-white tablets imprinted with EFL on one side and 192 on the other side. Actual size is ~11 mm in diameter.

References:

1. IWILFIN. Prescribing information. USWM, LLC; 2023